Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04163471 · ClinicalTrials.gov registry record
VasoStat vs. TR Band for Radial Hemostasis
A clinical trial of Coronary Artery Disease and Peripheral Arterial Disease, sponsored by Forge Medical.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT04163471: Completed study of Coronary Artery Disease and Peripheral Arterial Disease, sponsored by Forge Medical.
NCT04163471 is a study of Coronary Artery Disease and Peripheral Arterial Disease that has completed, run by Forge Medical. The registered enrollment target is 40 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04163471, a study of Coronary Artery Disease and Peripheral Arterial Disease, has completed, sponsored by Forge Medical.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
VasoStat vs. TR Band compression for Radial Artery Hemostasis Following Transradial Catheterization Without Prior Radial Artery Access
Primary Outcome
Changes in Hand perfusion will be quantified using a noninvasive pulse oximetry technique and a previously validated metric known as the Perfusion Index, which is the ratio of the pulsatile blood flow to the nonpulsatile or static blood in peripheral tissue. The Perfusion Index represents a noninvasive measure of hand perfusion that can be continuously and noninvasively obtained from a specialized pulse oximeter.
Conditions Studied
Interventions
- DEVICE Radial artery mechanical compression for hemostasis
Study Locations (1)
Montana
- Billings Clinic Heart and Vascular at Community Medical Center - Missoula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-06-04 |
| Est. Completion | 2019-05-01 |
What the finished NCT04163471 record still lists
NCT04163471 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Radial artery mechanical compression for hemostasis is the first listed.
NCT04163471 reports a single indexed study location in Montana.
Frequently Asked Questions
What is clinical trial NCT04163471 about?
NCT04163471 is a clinical study titled "VasoStat vs. TR Band for Radial Hemostasis". VasoStat vs. TR Band compression for Radial Artery Hemostasis Following Transradial Catheterization Without Prior Radial Artery Access
What is the current status of trial NCT04163471?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2018-06-04. Estimated completion is 2019-05-01.
What conditions does trial NCT04163471 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Peripheral Arterial Disease.
What interventions are being tested in trial NCT04163471?
The interventions under investigation include: Radial artery mechanical compression for hemostasis (DEVICE).
Who is sponsoring clinical trial NCT04163471?
This trial is sponsored by Forge Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04163471 being conducted?
This trial has 1 study location across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04163471's enrollment target sits among peer trials
40 188th of 219 higher than 27 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI